Photo for representational purpose only.
London, October 22
Moderna Inc said on Thursday it had completed enrolling 30,000 participants in a late-stage study testing its experimental coronavirus vaccine.
Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.
Moderna said its study includes more than 11,000 participants from minority communities in the US, representing 37 per cent of the study population. Reuters
Most Read
Don't Miss
Top Stories
Delhi Chalo march LIVE: Farmers reach near Delhi borders; face water cannons, tear gas
Bhartiya Kisan Union (Haryana) leader Gurnam Singh welcomed ...
Langar preparations under way to serve thousands of protesting farmers
Other special committees are serving food to thousands of un...
Supreme Court questions FIR against Arnab Goswami
A Bench headed by Justice DY Chandracuhd says prima facie th...
Kangana bungalow demolition smacks of malice, says Bombay High Court
Ranaut had sought Rs 2 crore in damages from the BMC and urg...
Navy's MiG-29K fighter jet crashes into sea near Goa
Search is on for one of the two pilots who had ejected
